Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Alan Lichtin

Main menu

Home
Content
Specialty
- Articles by Specialty
CME/MOC
- Articles
- Calendar
Info For
Conversations with Leaders
Conference Coverage
- MDS 2023
- IAS 2023
- ACP 2023
- AAN 2023
- ACC / WCC 2023
- AAAAI Meeting 2023
- ACR Convergence 2022
- Kidney Week 2022
- AIDS 2022
- CHEST 2021
- IDWeek 2021
- IAS 2021
- ADA 2021
- ATS 2021
- ACC 2021
- ACP 2021
- AAN 2021

Other Publications
- www.clevelandclinic.org

User menu

Search

Search for this keyword

Advanced search

Other Publications
- www.clevelandclinic.org

Search for this keyword

Advanced Search

Home
Content
Specialty
- Articles by Specialty
CME/MOC
- Articles
- Calendar
Info For
Conversations with Leaders
Conference Coverage
- MDS 2023
- IAS 2023
- ACP 2023
- AAN 2023
- ACC / WCC 2023
- AAAAI Meeting 2023
- ACR Convergence 2022
- Kidney Week 2022
- AIDS 2022
- CHEST 2021
- IDWeek 2021
- IAS 2021
- ADA 2021
- ATS 2021
- ACC 2021
- ACP 2021
- AAN 2021

Medical Grand Rounds

Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Alan Lichtin, MD

Cleveland Clinic Journal of Medicine November 1998, 65 (10) 510-514;

William S. Wilke

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alan Lichtin

Department of Hematology and Medical Oncology, Cleveland Clinic; member of the American Society of Hematology ITP Practice Guideline Panel

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

ABSTRACT

Clinical guidelines for treating ITP are based on the consensus of an expert panel, as randomized trials are lacking. Newer genetically engineered treatments hold promise but await definitive study.

PreviousNext

In this issue

Cleveland Clinic Journal of Medicine

Vol. 65, Issue 10

1 Nov 1998

Table of Contents
Table of Contents (PDF)
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Message Subject (Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body (Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Alan Lichtin

Cleveland Clinic Journal of Medicine Nov 1998, 65 (10) 510-514;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Alan Lichtin

Cleveland Clinic Journal of Medicine Nov 1998, 65 (10) 510-514;

Share This Article:

Tweet Widget
Facebook Like
Linkedin Share Button

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Navigate

Current Issue
Past Issues
Supplements
Article Type
Specialty
CME/MOC Articles
CME/MOC Calendar
Media Kit

Authors & Reviewers

Manuscript Submission
Authors & Reviewers
Subscriptions
About CCJM
Contact Us
Cleveland Clinic Center for Continuing Education
Consult QD

Share your suggestions!

Copyright © 2023 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy.

Main menu

User menu

Search

Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

ABSTRACT

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Navigate

Authors & Reviewers